TD SYNNEX (SNX) Form 4: Director Polk sells 3,000 shares on 08/04/2025

Q: Who filed the Form 4 for TD SYNNEX (SNX)?

The Form 4 was filed on behalf of Dennis Polk , identified as a Director and Hyve Solutions Executive .

Q: What transactions are reported on the SNX Form 4 dated 08/04/2025?

Reported sales on 08/04/2025 : 300 shares at a weighted-average price of $141.82 and 2,700 shares at a weighted-average price of $142.22 .

Q: Were the sales conducted under a trading plan?

Yes. The sales were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 10/13/2024 for the Polk family trust.

Q: When was the Form 4 signed?

The Form 4 bears the signature of /s/ Cheryl Grant, attorney-in-fact dated 08/05/2025 .

[Form 4] TD SYNNEX Corporation Insider Trading Activity

Filing Impact

(Neutral)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Form 4 filed for TD SYNNEX (SNX) by Dennis Polk. The filing reports insider sales on 08/04/2025 executed pursuant to a Rule 10b5-1 trading plan adopted October 13, 2024 on behalf of the Polk family trust.

Sales: 300 shares at a weighted-average price of $141.82 and 2,700 shares at a weighted-average price of $142.22.
Beneficial ownership reported after the transactions: 90,360 and 87,660 shares, held indirectly "By Trust."
Form signed by /s/ Cheryl Grant, attorney-in-fact on 08/05/2025.

The form also contains an additional Table I entry showing 35,295 with a disposition indicator "D" but lacking accompanying date, price or ownership columns in the provided excerpt.

Insights

TL;DR: Routine insider sales under a 10b5-1 plan; dates, quantities, and weighted prices are disclosed.

The filing shows Dennis Polk, a director and Hyve Solutions executive, executing sales on 08/04/2025 under a Rule 10b5-1 plan adopted 10/13/2024. Reported transactions: 300 shares at $141.82 (WAP) and 2,700 shares at $142.22 (WAP), with beneficial ownership after the trades reported as 90,360 and 87,660 shares held indirectly by a trust. The disclosure is precise on prices and plan provenance; an additional "35,295 D" row appears without date/price context in the excerpt. Impact assessment: not impactful given information provided; these are planned sales, not ad hoc disclosures.

TL;DR: Proper Form 4 disclosure of Rule 10b5-1 sales by a trustee; signature provided by attorney-in-fact.

The document identifies the reporting person as Dennis Polk and confirms relationship roles (Director; Hyve Solutions Executive). Sales were executed pursuant to a documented 10b5-1 plan on behalf of the Polk family trust, and the filing includes weighted-average price ranges and an attorney-in-fact signature dated 08/05/2025. Governance implication: disclosure aligns with procedural insider sale protocols. Impact assessment: not impactful based on stated facts alone.

08/05/2025 - 05:41 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

POLK DENNIS

(Last)

(First)

(Middle)

44201 NOBEL DRIVE

(Street)

FREMONT

94538

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
TD SYNNEX CORP [ SNX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Hyve Solutions Executive

3. Date of Earliest Transaction (Month/Day/Year)
08/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	08/04/2025		S⁽¹⁾		300	D	$141.82⁽²⁾	90,360	I	By Trust
Common Stock	08/04/2025		S⁽¹⁾		2,700	D	$142.22⁽³⁾	87,660	I	By Trust
Common Stock								35,295	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. These sales were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2024, on behalf of the Polk family trust of which the reporting person is a trustee.

2. Represents the weighted average sales price for a number of transactions effected at prices ranging from $141.70 to $141.90. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.

3. Represents the weighted average sales price for a number of transactions effected at prices ranging from $142.05 to $142.50. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.

	/s/ Cheryl Grant, attorney-in-fact	08/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

Who filed the Form 4 for TD SYNNEX (SNX)?

The Form 4 was filed on behalf of Dennis Polk, identified as a Director and Hyve Solutions Executive.

What transactions are reported on the SNX Form 4 dated 08/04/2025?

Reported sales on 08/04/2025: 300 shares at a weighted-average price of $141.82 and 2,700 shares at a weighted-average price of $142.22.

Were the sales conducted under a trading plan?

Yes. The sales were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 10/13/2024 for the Polk family trust.

How much SNX stock is shown as beneficially owned after the reported trades?

The filing shows beneficial ownership following reported transactions as 90,360 and 87,660 shares, held indirectly ("By Trust").

When was the Form 4 signed?

The Form 4 bears the signature of /s/ Cheryl Grant, attorney-in-fact dated 08/05/2025.

AG真人官方

[Form 4] TD SYNNEX Corporation Insider Trading Activity

Insights

FAQ

Who filed the Form 4 for TD SYNNEX (SNX)?

What transactions are reported on the SNX Form 4 dated 08/04/2025?

Were the sales conducted under a trading plan?

How much SNX stock is shown as beneficially owned after the reported trades?

When was the Form 4 signed?

NYSE:SNX

SNX Rankings

SNX Latest News

SNX Latest SEC Filings

SNX Stock Data

AG真人官方

Trending News

[Form 4] TD SYNNEX Corporation Insider Trading Activity

Insights

Financial Analyst neutral

Corporate Governance Expert neutral

FAQ

Who filed the Form 4 for TD SYNNEX (SNX)?

What transactions are reported on the SNX Form 4 dated 08/04/2025?

Were the sales conducted under a trading plan?

How much SNX stock is shown as beneficially owned after the reported trades?

When was the Form 4 signed?

NYSE:SNX

SNX Rankings

SNX Latest News

SNX Latest SEC Filings

SNX Stock Data